🩺 Therapie
partial reprogramming (osk)
Partial cellular reprogramming with Yamanaka factors (OSK). Strong evidence in ANIMALS that it restores youthful cell function and reverses vision loss — preclinical, not a human therapy yet.
2 well-supported · 0 disputed. This shows how settled each sub-question is, not whether partial reprogramming (osk) is "good." Direction lives in each claim below.
The 2 claims about partial reprogramming (osk)
Each keeps its own verdict — we never average them away.
Can resetting cells make tissues young again?
Leans support 🐭 Non-human evidence Yes, but only shown in animals so far, with zero human data and real tumor-risk concerns.
Can gene "reprogramming" reverse age-related vision loss?
Leans support 🐭 Non-human evidence Yes, it restored sight after injury and ageing, but only shown in mice so far, with no human data.
Educational only, not medical advice. Hub descriptions are curated for honesty; see the methodology.